IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome

Lupus

Volumn 13, Issue 6, 2004, Pages 478-480

  Horn, Hans Christian ^a   Grau, K ^b   Junker, P ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b KOLDING HOSPITAL   (Denmark)

Author keywords

Antiphospholipid antibody syndrome; Intravenous immunoglobulin; Stroke in progression

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; GLUCOCORTICOID; HEPARIN; HYDROCORTISONE; IMMUNOGLOBULIN; LIVER ENZYME; METHYLPREDNISOLONE;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN INFARCTION; CASE REPORT; CESAREAN SECTION; FEMALE; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PREMATURE LABOR; PRIORITY JOURNAL; STROKE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY;

EID: 3142680922     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1035cr     Document Type: Article

References (10)

1. Imbach P, Barandun S, d'Apuzzo et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228-1231.
2. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain Barre Study Group. N Engl J Med 1992; 326: 1123-1129.
3. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol 1997; 41: 789-796.
4. Achiron A, Gabbay U, Gilad R et al. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 1998; 50: 398-402.
5. Saadeh C, Bridges W, Burwick F. Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin. South Med J 1995; 88: 866-870.
6. Clark AL, Branch DW, Silver RM, Harris EN, Pierangeli S, Spinnato JA. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy. Obstet Gynecol 1999; 93: 437-441.
7. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019-1027.
8. Atsumi T, Khamashta MA, Haworth RS et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998; 41: 800-807.
9. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-755.
10. Gordon C, Kilby MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Lupus 1998; 7: 429-433.